Abstract
Purpose:
To investigate the role of senescence-related cytokines (SRCs) in the pathophysiology of age-related macular degeneration (AMD).
Design:
The whole study is based on single-cell and bulk tissue transcriptomic analysis of the human neuroretinas with or without AMD. The transcriptomic data of human neuroretinas was obtained from Gene-Expression Omnibus (GEO) database.
Methods:
For single-cell transcriptomic analysis, the gene expression matrix goes through quality control (QC) filtering, being normalized, scaled and integrated for downstream analysis. The further analyses were performed using Seurat R package and CellChat R package. After cell type annotation, the expression of phenotype and functional markers of microglia was investigated and cell-cell communication analysis was performed. For bulk tissue transcriptomic analysis, GSE29801 dataset contains the transcriptomic data of human macular neuroretina (n = 118) from control group and AMD patients. The expression of SPP1 in control and AMD subtypes were compared by Student’s t-test. In addition, the AMD macular neuroretina were classified into SPP1-low and SPP1-high groups according to the expression level of SPP1. The differentially expressed genes between these two groups were subsequently identified and the pathway enrichment analysis for these genes was further conducted.
Results:
Secreted phosphoprotein 1, as an SRC, was revealed to be highly expressed in microglia of AMD neuroretina and the SPP1-receptor signaling was highly activated in AMD neuroretina. In addition, SPP1 signaling was associated with the pro-inflammatory phenotype and phagocytic state of microglia. SPP1 expression was elevated in macular neuroretina with late dry and wet AMD and the inflammatory pathways were found to be activated in SPP1-high AMD macular neuroretina.
Conclusion:
Our findings indicated that SPP1 and microglial activation might play an important role in the pathophysiology of AMD. Therefore, SPP1 might serve as a potential therapeutic target for AMD. More in vitro and in vivo studies are required to confirm the results and the therapeutic effect of SPP1-targeting strategy.
1 Introduction
Worldwide, the growing incidence of age-related diseases have imposed a major socioeconomic and public health challenge. Aging is a major risk factor for several vision-threatening diseases affecting the retina, including age-related macular degeneration (AMD). AMD is a widely diagnosed neurodegenerative disease, which affects the macula (the most important part of the retina) (Wong et al., 2014) and has been associated with visual impairment and considerable health burden (; Zhu et al., 2019). The number of individuals affected by AMD is keeping increasing (; Wong et al., 2014). Despite recent efforts and advances, the mechanisms underlying the AMD pathophysiology is still not fully understood.
Intravitreal injection of anti-vascular endothelial growth factor (VEGF), including ranibizumab () and aflibercept (Wykoff et al., 2023), have been used to slow the progression of the neovascular/wet subtype (nAMD/wAMD). However, since nAMD patients may not show response to anti-VEGF treatment () and there is no effective treatment available for atrophic/dry AMD, there is still an urgent need for further investigation of the pathogenesis and treatment options.
Cellular senescence has been suggested to play a critical role (; ) in AMD initiation and development. As a hallmark of aging, cellular senescence is a significant contributor to aging and age-related diseases including AMD (). Notably, has identified a gene set (senescence-related genes, SRGs) for predicting senescence-associated pathways across tissues, which has been used and cited by many researches about age-related diseases (; ; Yu et al., 2023). Importantly, the senescence-related cytokines (SRCs) were the key part of this senescence-related gene set.
In this study, we investigated the expression and potential role of SRCs in the pathophysiology of AMD. As a result, single-cell and bulk tissue transcriptomic analysis showed that SPP1 was the most important SRC in the development of AMD and revealed the vital role of SPP1 signaling and microglial activation in AMD development.
2 Materials and methods
2.1 Single-cell transcriptomic analysis
The list of 35 SRCs was obtained from (Supplementary Table 1). We obtained single-cell RNA (scRNA) sequencing data of AMD neuroretina from GSE137537 dataset in Gene-Expression Omnibus (GEO) database. In this dataset, isolated and sequenced neuroretinal cells from neuroretinal suspensions of three postmortem human eyes diagnosed with AMD. Following quality control (QC) filtering, the gene expression matrix was normalized, scaled and integrated for downstream analysis (). The further analyses were performed using Seurat R package (version 4.0) () and CellChat R package (version 1.6.1) (). To assign cluster identities, the markers of clusters were identified by using the FindAllMarkers function in Seurat. Clustering and uniform manifold approximation and projection (UMAP) dimensional reduction were performed and cell annotation markers provided by the authors of the dataset () were used to identify the cell types in the neuroretina tissue including: Amacrine cell (GAD1, C1QL2), Bipolar cell (CAMK2B, GRM6, TMEM215, TRPM1), Cone (GNAT2, OPN1SW, OPN1MW, OPN1LW), Endothelial cell (CD34, CDH5, RGS5, ADAMTS9, DLL4, FLT1, KDR, VWF), Horizontal cell (ONECUT1, ONECUT2, LHX1), Microglia (C1QA, TMEM119, AIF1, CD163), Müller glia and Astrocyte (GLUL, CLU, APOE), Retinal ganglion cell (NEFM, SLC17A6), Rod (PDE6A, PPEF2, NR2E3) (Supplementary Table 2). Visualization of gene expression was generated using the functions in the Seurat package.
To explore the cell-cell communications between retinal cell types from scRNA sequencing data, CellPhoneDB database1 was used to perform ligand-receptor pairing analysis (), which contains summarized set of protein-protein interactions (PPI). CellPhoneDB statistical analysis was performed using the “secreted signaling” set (cytokines and chemokines) between all cell populations.
2.2 Bulk tissue transcriptomic analysis
The bulk tissue RNA sequencing data of human macular neuroretina samples were also obtained from GEO database. GSE29801 reported the bulk tissue transcriptomic atlas of human macular neuroretina (n = 118) from control group and AMD patients (). The AMD macular neuroretinas were classified into three subtypes, including early AMD, late dry AMD (geographic atrophy, GA) and wet/neovascular AMD, according to Age Related Eye Disease Studies (AREDS).
The expression of SPP1 in control and AMD subtypes were compared. In addition, the AMD macular neuroretinas were classified into SPP1-low and SPP1-high groups according to the expression level of SPP1. The differentially expressed genes (DEGs) between these two groups were subsequently identified. The criteria for DEGs were adjusted P < 0.05 and | log (FC) | > 1. The pathway enrichment analysis for these DEGs was performed via Metascape database.2
2.3 Statistical analysis
R software (version 4.0.1) and GraphPad Prism (version 8.0) was used for statistical analysis. Values between two groups were compared using Student’s t-test or Wilcoxon rank-sum test. All P-values were two-sided and the threshold for significance was set as P < 0.05.
3 Results
3.1 SRCs expression and cell-cell communications in AMD retina
Through quality control (QC) filtering, normalization and cell type annotation, 9 types of neuroretinal cells were identified: 2,832 Retinal ganglion cells (RGCs); 4,741 Rods; 1,989 Bipolar cells; 2,548 Macroglia (Müller glia and Astrocyte); 986 Horizontal cell; 535 Amacrine cells; 869 Microglia; 219 Cones; and 245 Endothelial cells (Figures 1A, B). The expression of SRCs was investigated and single-cell transcriptomic analysis showed that SPP1 was a highly expressed SRC in AMD neuroretina, which was mainly expressed in Microglia, Müller glia and Astrocyte, and Endothelial cells in AMD neuroretina (Figure 1C). Notably, cell-cell communication analysis (secreted signaling) showed that neuroretinal cells communicated frequently with each other (Figure 2A) and the SPP1-(ITGAV + ITGB1) signaling was highly activated in AMD neuroretina (Figure 2B). ITGAV (Integrin Subunit Alpha V) and ITGB1 (Integrin Subunit Beta 1) belong to integrin family and can act as the receptors of SPP1 (; ). In addition, SPP1-(ITGAV + ITGB1) signaling existed in Müller glia and Astrocyte to Microglia, Endothelial cells to Microglia, and Microglia to Microglia (Figure 2C). Therefore, we investigated all the secreted communications between microglia and other neuroretinal cells and the results indicated that SPP1-(ITGAV + ITGB1) signaling stimulated and activated microglia through paracrine and autocrine ways (Figures 3A, B).
FIGURE 1
FIGURE 2
FIGURE 3
The protein-protein interaction (PPI) network from String database showed that SPP1 could interact with multiple receptors including CD44, ITGAV, ITGA9, ITGB1, and ITGB3 and non-receptor factors such as MMP3 and MMP7 (Figure 4A). Previous publications suggested that SPP1-receptor signaling in microglia could lead to the elevated expression of proinflammatory genes, promote phagocytosis and cell migration (Figure 4B; ).
FIGURE 4
Subsequently, the expression of phenotype and functional markers of microglia in AMD neuroretina was investigated. The results showed that inflammatory cytokines (including IL1B, IL6, and TNF) (), microglial phagocytic markers (CTSB, GRN, and C1QA) (), cell migration signatures (FAK, RAC1, and CDC42) (), and classic disease-associated microglia (DAM) markers (IBA1, CST3, HEXB, APOE, and TREM2) () were upregulated in microglia, while the anti-inflammatory cytokines (IL10 and TGFB) () were at low expression levels in microglia (Figure 5A). Pathway enrichment analysis was then performed and the mainly upregulated pathways in microglia of AMD neuroretina included phagocytosis-related pathways (Phagosome, Microglia phagocytosis pathway, Synapse pruning, Regulation of cell killing, and Positive regulation of neuron death), complete activation-associated pathways (C1q complex and Complete activation), inflammation-related pathways (IL-18 signaling pathway and Regulation of inflammatory response) and Regulation of chemotaxis pathway (Figure 5B).
FIGURE 5
3.2 SPP1 expression and associated pathways in AMD macular neuroretina
Bulk transcriptomic analysis showed that SPP1 expression was significantly elevated in macular neuroretina with GA and neovascular/wet AMD (P < 0.05), compared to normal ones (Figure 6A). The DEGs between SPP1-low and SPP1-high AMD neuroretina were identified (Figure 6B).
FIGURE 6
The upregulated pathways in SPP1-high AMD macular neuroretina included angiogenesis-related pathways (blood vessel development and angiogenesis), glia-activation pathways (gliogenesis, glial cell proliferation, glial cell differentiation, and glial cell development), Inflammatory response pathway, and Endothelial cell proliferation pathway (Figure 6C).
4 Discussion
There are several stages of AMD, i.e., the early stage and the late or advanced stages. The important characteristic of the former is the occurrence of drusen, which is the extracellular accumulation of lipid, minerals and proteins (). The late or advanced stages of this disease can be classified into atrophic/dry and neovascular/wet forms (nAMD). The atrophic/dry form of AMD could end as the extensive atrophy of whole layers of the retina, called geographic atrophy (GA). While nAMD is characterized by the formation of choroidal neovascularization (CNV) (). For atrophic/dry AMD, there is no effective treatment available. For nAMD, the anti-VEGF therapy is also limited as patients with nAMD may not show response to this treatment. Therefore, it is urgently needed to further investigate the pathophysiology and develop novel therapeutic targets.
Secreted phosphoprotein 1 (SPP1)/Osteopontin (OPN) is a protein with multiple functions and widely expressed in tissues of human body (). Recently, the upregulation of SPP1 has been revealed in various autoimmune diseases [including systemic lupus erythematosus (Wong et al., 2005)], inflammatory diseases [including Crohn’s disease () and multiple sclerosis (MS) ()], and neurodegenerative diseases (NDDs) such as Alzheimer’s disease (AD) (Wung et al., 2007; ). In addition, AMD is also one type of NDDs. Therefore, the role of SPP1 in pathophysiology of AMD is worthy of further investigation.
Currently, microglia, as one type of neuroglial cells, have been found to closely interact with other cells in both central and peripheral nervous system, which is important for the maintenance of nervous tissues. Notably, it has been suggested that the migration of activated microglia to the ongoing retinal lesion and their phenotype transformation are the hallmarks of AMD pathogenesis (Zhao et al., 2023). In addition, the crosstalk between microglia, Müller glia and astrocyte plays an important role in AMD pathology process (; Zhao et al., 2023). In this study, cell-cell communication analysis showed that Müller glia and astrocyte interact with microglia via secreted SPP1. Moreover, the expression of cell-migration signatures (FAK, RAC1, and CDC42) () was elevated in microglia of AMD neuroretina. The glial activation pathways were also activated in SPP1-high AMD macular neuroretina. These results indicated the important role of SPP1 in this AMD-promoting crosstalk between glial cells.
Activated microglia, similar to peripheral macrophages, have two primary polarization phenotypes: M1 (classical activation) and M2 (alternative activation) (Wolf et al., 2017). M1-phenotype microglia mainly play a pro-inflammatory role and promote the synthesis of inflammatory mediators such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), which can promote chronic neuroinflammation, phagocytosis, and neurodegeneration and inhibit regeneration (). Therefore, M1 microglia often have obvious neurotoxic effects (). In contrast, the M2-phenotype microglia are alternatively activated microglia, which release neuroprotective and anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), to exert anti-inflammatory effects, promote wound healing, neuroprotection, and tissue repair (). Therefore, M2 microglia often have neuroprotective effects (). In this study, single-cell sequencing analysis showed that inflammatory cytokines were upregulated and anti-inflammatory cytokines were downregulated in retinal microglia of AMD neuroretina, which indicated the neurotoxic M1-phenotype, instead of neuroprotective M2-phenotype, of microglia in AMD development and highlighted the important role of activated microglia in the formation of neuroinflammation in AMD.
Phagocytosis of microglia has been implicated in NDDs. For example, in AD, the phagocytic function of microglia plays a dual role. On the one hand, it can promote the clearance of toxic Aβ peptides (Zeng et al., 2023); on the other hand, the phagocytic state in microglia induces synaptic engulfment and subsequent synaptic loss and neuron death in AD (). Notably, the loss of photoreceptors and synapse elimination has been observed in AMD (Yednock et al., 2022). In AMD, the injury of blood-retinal barrier allows leakage of serum proteins, including C1q and other complement components, into the retina from the underlying choriocapillaris (). Local complement activation leads to the recruitment of microglia into the lesion, which then produce additional C1q and other complement components, prune complement-coated synapses away from neurons, depriving neurons of trophic support, and cause neuroinflammation that adds to neuronal damage and loss (). In this study, we noticed the high expression of C1QA and other phagocytic markers including CTSB and GRN () in microglia of AMD neuroretina. The phagocytosis, cell killing and chemotaxis pathways were also found to be activated in microglia of AMD neuroretina. Interestingly, reported that SPP1 could induce the phagocytic state and the neuron damage effects in microglia in AD. Publications also suggested that SPP1 could promote phagocytosis and cell migration of microglia (). These results indicated that SPP1 may promote the development of AMD by activating and inducing the phagocytic state of retinal microglia, thereby causing damage to photoreceptors and corresponding visual impairment.
The important role of the special status of microglia, called disease-associated microglia (DAMs), in NDDs has been revealed by studies (). DAMs have unique patterns of gene expression and are associated with neuroinflammatory and neurodegenerative conditions (; ; ; ; ). DAMs are characterized by expressing typical microglial markers, IBA1, CST3, and HEXB (), which were observed to be highly expressed in microglia of AMD neuroretina in this study. DAMs further display upregulation of genes involved in lysosomal, phagocytic, and lipid metabolism pathways, such as APOE and TREM2, which are known AD risk factors (). Moreover, previous studies have suggested the potential synergy between complete system and TREM2-APOE signaling in inducing synaptic pruning of microglia and neuron loss in AD (; ). Interestingly, results in this study found the activation of both complete system and TREM2-APOE signaling in microglia of AMD neuroretina, indicating the synergy between these two systems also existed in AMD development. Notably, high expression of SPP1 has been identified as an important characteristic of the DAMs in AD brain (). Therefore, SPP1 may stimulate microglia and contribute to synaptic loss and death of photoreceptors via these two mechanisms.
Moreover, the angiogenesis-related pathways were found to be activated in SPP1-high AMD macular neuroretina. In addition, SPP1 expression was also elevated in macular neuroretina with neovascular/wet AMD. Interestingly, a previous study has revealed that the SPP1 expression is upregulated in laser-induced CNV and microglia in CNV membranes from patients with neovascular AMD (). It has also been suggested that SPP1 may promote angiogenesis by stimulating integrin receptor signaling and then PI3K/AKT- and ERK1/2 signaling pathways in endothelial cells (). Of note, a recent study demonstrated that intravitreal injection of an SPP1-blocking antibody could reduce CNV sizes in mice ().
Collectively, the results indicated that SPP1 might activate retinal microglia, thereby inducing the synaptic loss and subsequent death of photoreceptors, neuroinflammation, and the formation of pro-angiogenesis microenvironment during AMD development (Figure 7). Therefore, SPP1 might serve as a potential therapeutic target for AMD. Still, further in vitro and in vivo studies are required to confirm the results and the therapeutic effect of SPP1-based strategy.
FIGURE 7
Statements
Data availability statement
The original contributions presented in this study are included in this article/Supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
This study used only publicly available, deidentified data from previously published works, making it exempt according to the Wuhan Fourth Hospital institutional review board. Our research adhered to the tenets of the Declaration of Helsinki.
Author contributions
SL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Visualization, Writing—original draft. MH: Conceptualization, Data curation, Formal analysis, Writing—original draft. ZW: Conceptualization, Methodology, Supervision, Writing—review and editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fncel.2023.1322451/full#supplementary-material
Abbreviations
SRC, senescence-related cytokine; AMD, age-related macular degeneration; GEO, Gene-Expression Omnibus; QC, quality control; DEGs, differentially expressed genes; VEGF, vascular endothelial growth factor; nAMD, neovascular age-related macular degeneration; wAMD, wet age-related macular degeneration; AD, Alzheimer's disease; SRGs, senescence-related genes; scRNA, single-cell RNA; UMAP, uniform manifold approximation and projection; L-R, ligand-receptor; AREDS, age related eye disease studies; GA, geographic atrophy; SPP1, secreted phosphoprotein 1; OPN, osteopontin; DAMs, disease-associated microglia; SASP, senescenceassociated secretory phenotype; CNV, choroidal neovascularization.
References
1
BeguierF.HoussetM.RoubeixC.AugustinS.ZagarY.NousC.et al (2020). The 10q26 risk haplotype of age-related macular degeneration aggravates subretinal inflammation by impairing monocyte elimination.Immunity53429–441.e428. 10.1016/j.immuni.2020.07.021
2
BlodiB. A.DomalpallyA.CorkeryE.OsborneA.BlotnerS.GrzeschikS. M.et al (2023). Prevalence of macular atrophy in the MARINA study of ranibizumab versus sham for neovascular age-related macular degeneration.Ophthalmol. Retina7661–671. 10.1016/j.oret.2023.03.004
3
ButlerA.HoffmanP.SmibertP.PapalexiE.SatijaR. (2018). Integrating single-cell transcriptomic data across different conditions, technologies, and species.Nat. Biotechnol.36411–420.
4
ButovskyO.JedrychowskiM. P.MooreC. S.CialicR.LanserA. J.GabrielyG.et al (2014). Identification of a unique TGF-β-dependent molecular and functional signature in microglia.Nat. Neurosci.17131–143.
5
CappellanoG.VecchioD.MagistrelliL.ClementeN.RaineriD.Barbero MazzuccaC.et al (2021). The Yin-Yang of osteopontin in nervous system diseases: damage versus repair.Neural Regen. Res.161131–1137. 10.4103/1673-5374.300328
6
ChabasD.BaranziniS. E.MitchellD.BernardC. C.RittlingS. R.DenhardtD. T.et al (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.Science2941731–1735.
7
ComiC.CarecchioM.ChiocchettiA.NicolaS.GalimbertiD.FenoglioC.et al (2010). Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer’s disease and its levels correlate with cognitive decline.J. Alzheimers Dis.191143–1148.
8
CongdonN.O’ColmainB.KlaverC. C.KleinR.MuñozB.FriedmanD. S.et al (2004). Causes and prevalence of visual impairment among adults in the United States.Arch. Ophthalmol.122477–485.
9
CuencaN.Fernández-SánchezL.CampelloL.ManeuV.De la VillaP.LaxP.et al (2014). Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases.Prog. Retin. Eye Res.4317–75. 10.1016/j.preteyeres.2014.07.001
10
DaiJ.PengL.FanK.WangH.WeiR.JiG.et al (2009). Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.Oncogene283412–3422.
11
De SchepperS.GeJ. Z.CrowleyG.FerreiraL. S. S.GarceauD.ToomeyC. E.et al (2023). Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease.Nat. Neurosci.26406–415. 10.1038/s41593-023-01257-z
12
DeczkowskaA.Keren-ShaulH.WeinerA.ColonnaM.SchwartzM.AmitI. (2018). Disease-associated microglia: a universal immune sensor of neurodegeneration.Cell1731073–1081. 10.1016/j.cell.2018.05.003
13
DonosoL. A.VrabecT.KuivaniemiH. (2010). The role of complement Factor H in age-related macular degeneration: a review.Surv. Ophthalmol.55227–246.
14
DoolittleM. L.SaulD.KaurJ.RowseyJ. L.VosS. J.PavelkoK. D.et al (2023). Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton.Nat. Commun.14:4587.
15
EfremovaM.Vento-TormoM.TeichmannS. A.Vento-TormoR. (2020). CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes.Nat. Protoc.151484–1506. 10.1038/s41596-020-0292-x
16
FangS.WuZ.GuoY.ZhuW.WanC.YuanN.et al (2023). Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics.Front. Immunol.14:1193053. 10.3389/fimmu.2023.1193053
17
FarrJ. N. (2023). Skeletal senescence with aging and Type 2 diabetes.Endocrinol. Metab. (Seoul, Korea)38295–301.
18
FleckensteinM.KeenanT. D. L.GuymerR. H.ChakravarthyU.Schmitz-ValckenbergS.KlaverC. C.et al (2021). Age-related macular degeneration.Nat. Rev. Dis. Primers7:31.
19
GribovA.SillM.LückS.RückerF.DöhnerK.BullingerL.et al (2010). SEURAT: visual analytics for the integrated analysis of microarray data.BMC Med. Genomics3:21. 10.1186/1755-8794-3-21
20
HollowayK.NeherinK.DamK. U.ZhangH. (2023). Cellular senescence and neurodegeneration.Hum. Genet.1421247–1262.
21
JordãoM. J. C.SankowskiR.BrendeckeS. M.Sagar, LocatelliG.TaiY. H.et al (2019). Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation.Science363:eaat7554. 10.1126/science.aat7554
22
KatschkeK. J.Jr.XiH.CoxC.TruongT.MalatoY.LeeW. P.et al (2018). Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.Sci. Rep.8:7348.
23
KauppinenA.PaternoJ. J.BlasiakJ.SalminenA.KaarnirantaK. (2016). Inflammation and its role in age-related macular degeneration.Cell. Mol. Life Sci.731765–1786.
24
Keren-ShaulH.SpinradA.WeinerA.Matcovitch-NatanO.Dvir-SzternfeldR.UllandT. K.et al (2017). A unique microglia type associated with restricting development of Alzheimer’s disease.Cell1691276–1290.e1217. 10.1016/j.cell.2017.05.018
25
KieferM. C.BauerD. M.BarrP. J. (1989). The cDNA and derived amino acid sequence for human osteopontin.Nucleic Acids Res.17:3306.
26
KwonH. S.KohS. H. (2020). Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.Transl. Neurodegener.9:42.
27
LambertJ. C.Ibrahim-VerbaasC. A.HaroldD.NajA. C.SimsR.BellenguezC.et al (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease.Nat. Genet.451452–1458. 10.1038/ng.2802
28
Linnartz-GerlachB.BodeaL. G.KlausC.GinolhacA.HalderR.SinkkonenL.et al (2019). TREM2 triggers microglial density and age-related neuronal loss.Glia67539–550.
29
LiuL. R.LiuJ. C.BaoJ. S.BaiQ. Q.WangG. Q. (2020). Interaction of microglia and astrocytes in the neurovascular unit.Front. Immunol.11:1024. 10.3389/fimmu.2020.01024
30
LiuZ.SunD.WangC. (2022). Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information.Genome Biol.23:218.
31
MasudaT.SankowskiR.StaszewskiO.BöttcherC.AmannL.Sagaret al (2019). Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.Nature566388–392.
32
MenonM.MohammadiS.Davila-VelderrainJ.GoodsB. A.CadwellT. D.XingY.et al (2019). Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration.Nat. Commun.10:4902.
33
NewmanA. M.GalloN. B.HancoxL. S.MillerN. J.RadekeC. M.MaloneyM. A.et al (2012). Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks.Genome Med.4:16. 10.1186/gm315
34
O’KorenE. G.YuC.KlingebornM.WongA. Y. W.PriggeC. L.MathewR.et al (2019). Microglial function is distinct in different anatomical locations during retinal homeostasis and degeneration.Immunity50723–737.e727. 10.1016/j.immuni.2019.02.007
35
OrihuelaR.McPhersonC. A.HarryG. J. (2016). Microglial M1/M2 polarization and metabolic states.Br. J. Pharmacol.173649–665.
36
PrinzM.JungS.PrillerJ. (2019). Microglia biology: one century of evolving concepts.Cell179292–311.
37
RosmusD. D.LangeC.LudwigF.AjamiB.WieghoferP. (2022). The role of osteopontin in microglia biology: current concepts and future perspectives.Biomedicines10:840. 10.3390/biomedicines10040840
38
SatoT.NakaiT.TamuraN.OkamotoS.MatsuokaK.SakurabaA.et al (2005). Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response.Gut541254–1262. 10.1136/gut.2004.048298
39
SaulD.KosinskyR. L.AtkinsonE. J.DoolittleM. L.ZhangX.LeBrasseurN. K.et al (2022). A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues.Nat. Commun.13:4827. 10.1038/s41467-022-32552-1
40
SchlechtA.ZhangP.WolfJ.ThienA.RosmusD. D.BonevaS.et al (2020). Secreted phosphoprotein 1 expression in retinal mononuclear phagocytes links murine to human choroidal neovascularization.Front. Cell Dev. Biol.8:618598. 10.3389/fcell.2020.618598
41
ShiY.HoltzmanD. M. (2018). Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.Nat. Rev. Immunol.18759–772. 10.1038/s41577-018-0051-1
42
StephanA. H.BarresB. A.StevensB. (2012). The complement system: an unexpected role in synaptic pruning during development and disease.Annu. Rev. Neurosci.35369–389.
43
TangY.LeW. (2016). Differential roles of M1 and M2 microglia in neurodegenerative diseases.Mol. Neurobiol.531181–1194.
44
TaylorD. J.HobbyA. E.BinnsA. M.CrabbD. P. (2016). How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review.BMJ Open6:e011504. 10.1136/bmjopen-2016-011504
45
TenbrockL.WolfJ.BonevaS.SchlechtA.AgostiniH.WieghoferP.et al (2022). Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives.Cell Tissue Res.387361–375. 10.1007/s00441-021-03514-8
46
WaiP. Y.KuoP. C. (2004). The role of Osteopontin in tumor metastasis.J. Surg. Res.121228–241.
47
WieghoferP.HagemeyerN.SankowskiR.SchlechtA.StaszewskiO.AmannL.et al (2021). Mapping the origin and fate of myeloid cells in distinct compartments of the eye by single-cell profiling.EMBO J.40:e105123. 10.15252/embj.2020105123
48
WolfS. A.BoddekeH. W.KettenmannH. (2017). Microglia in physiology and disease.Annu. Rev. Physiol.79619–643.
49
WongC. K.LitL. C.TamL. S.LiE. K.LamC. W. (2005). Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus.Rheumatology (Oxf.)44602–606. 10.1093/rheumatology/keh558
50
WongW. L.SuX.LiX.CheungC. M.KleinR.ChengC. Y.et al (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.Lancet Glob. Health2e106–e116. 10.1016/S2214-109X(13)70145-1
51
WungJ. K.PerryG.KowalskiA.HarrisP. L.BishopG. M.TrivediM. A.et al (2007). Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer’s disease brain.Curr. Alzheimer Res.467–72. 10.2174/156720507779939869
52
WykoffC. C.BrownD. M.ReedK.BerlinerA. J.GerstenblithA. T.BreaznaA.et al (2023). Effect of high-dose intravitreal aflibercept, 8 mg, in patients with neovascular age-related macular degeneration: the phase 2 CANDELA randomized clinical trial.JAMA Ophthalmol.141834–842. 10.1001/jamaophthalmol.2023.2421
53
YednockT.FongD. S.LadE. M. (2022). C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration.Int. J. Retina Vitreous8:79. 10.1186/s40942-022-00431-y
54
YuS.ChenM.XuL.MaoE.SunS. (2023). A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.Front. Immunol.14:1175490. 10.3389/fimmu.2023.1175490
55
ZengX.CheungS. K. K.ShiM.OrP. M. Y.LiZ.LiuJ. Y. H.et al (2023). Astrocyte-specific knockout of YKL-40/Chi3l1 reduces Aβ burden and restores memory functions in 5xFAD mice.J. Neuroinflammation20:290.
56
ZhaoN.HaoX. N.HuangJ. M.SongZ. M.TaoY. (2023). Crosstalk between microglia and Müller glia in the age-related macular degeneration: role and therapeutic value of neuroinflammation.Aging Dis.10.14336/AD.2023.0823-3[Epub ahead of print].
57
ZhuZ.WangW.KeelS.ZhangJ.HeM. (2019). Association of age-related macular degeneration with risk of all-cause and specific-cause mortality in the national health and nutrition examination survey, 2005 to 2008.JAMA Ophthalmol.137248–257. 10.1001/jamaophthalmol.2018.6150
Summary
Keywords
age-related macular degeneration, senescence, SPP1, microglia, single-cell RNA sequencing
Citation
Lei S, Hu M and Wei Z (2024) Single-cell sequencing reveals an important role of SPP1 and microglial activation in age-related macular degeneration. Front. Cell. Neurosci. 17:1322451. doi: 10.3389/fncel.2023.1322451
Received
20 October 2023
Accepted
15 December 2023
Published
08 January 2024
Volume
17 - 2023
Edited by
Eleni Beli, Queen’s University Belfast, United Kingdom
Reviewed by
Wenxin Ma, National Eye Institute (NIH), United States
Ana Isabel Arroba, Fundación para la Gestión de la Investigación Biomédica de Cádiz, Spain
Updates
Copyright
© 2024 Lei, Hu and Wei.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhongtao Wei, weizhongtao2023@126.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.